Literature DB >> 1671448

Streptococcus mitis and ARDS in neutropenic patients.

P H McWhinney, S H Gillespie, C C Kibbler, A V Hoffbrand, H G Prentice.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1671448     DOI： 10.1016/0140-6736(91)91205-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  Oral complications of cancer.

Authors: 
Journal:  BMJ       Date:  1991-04-06

2.  E test versus agar dilution for antimicrobial susceptibility testing of viridans group streptococci.

Authors:  S J Rosser; M J Alfa; S Hoban; J Kennedy; G K Harding
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

3.  In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients.

Authors:  F Alcaide; J Carratala; J Liñares; F Gudiol; R Martin
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

Review 4.  The Pathogenic Involvement of Neutrophils in Acute Respiratory Distress Syndrome and Transfusion-Related Acute Lung Injury.

Authors:  Johan Rebetz; John W Semple; Rick Kapur
Journal:  Transfus Med Hemother       Date:  2018-09-21       Impact factor: 3.747

5.  Evaluation of penicillin G in the prevention of streptococcal septicaemia in patients with acute myeloid leukaemia undergoing cytotoxic chemotherapy.

Authors:  P de Jong; M de Jong; E Kuijper; J van der Lelie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

6.  A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis.

Authors:  W V Kern; B Hay; P Kern; R Marre; R Arnold
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

7.  Pre-emptive administration of corticosteroids prevents the development of ARDS associated with Streptococcus mitis bacteremia following chemotherapy with high-dose cytarabine.

Authors:  E C Dompeling; J P Donnelly; J M Raemaekers; B E De Pauw
Journal:  Ann Hematol       Date:  1994-08       Impact factor: 3.673

8.  Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States.

Authors:  G V Doern; M J Ferraro; A B Brueggemann; K L Ruoff
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

9.  Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin.

Authors:  P H McWhinney; S Patel; R A Whiley; J M Hardie; S H Gillespie; C C Kibbler
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

10.  Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study.

Authors:  R Ramphal; M Bolger; D J Oblon; R J Sherertz; J D Malone; K H Rand; M Gilliom; J W Shands; B S Kramer
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.